Subhayan Chattopadhyay1,2, Hauke Thomsen1, Niels Weinhold3, Iman Meziane1, Stefanie Huhn3, Miguel Inacio da Silva Filho1, Pavel Vodicka4,5,6, Ludmila Vodickova4,5,6, Per Hoffmann7,8, Markus M Nöthen7,9, Karl-Heinz Jöckel10, Börge Schmidt10, Stefano Landi11, Roman Hajek12, Göran Hallmans13, Ulrika Pettersson-Kymmer14, Claes Ohlsson15, Paolo Milani16, Giampaolo Merlini16, Dorota Rowcieno17, Philip Hawkins17, Ute Hegenbart3, Giovanni Palladini16, Ashutosh Wechalekar17, Stefan O Schönland3, Richard Houlston18,19, Hartmut Goldschmidt3,20, Kari Hemminki1,2,6, Asta Försti21,22,23. 1. Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany. 2. Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany. 3. Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany. 4. Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Videnska 1083, 142 00, Prague, Czech Republic. 5. Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Albertov 4, 128 00, Prague, Czech Republic. 6. Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, 30605, Pilsen, Czech Republic. 7. Institute of Human Genetics, University of Bonn, Bonn, Germany. 8. Department of Biomedicine, University of Basel, Basel, Switzerland. 9. Department of Genomics, Life & Brain Research Center, University of Bonn, Bonn, Germany. 10. Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. 11. Department of Biology, University of Pisa, Pisa, Italy. 12. Department of Hematooncology, University Hospital Ostrava, 17. listopadu 1790, 708 52, Ostrava, Czech Republic. 13. Department of Medical Biosciences/Pathology, University of Umea, Umea, Sweden. 14. Clinical Pharmacology, Department of Pharmacology and Clinical Neuroscience, Umea University, Umea, Sweden. 15. Centre for Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 16. Amyloidosis Research and Treatment Center, Foundation "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo" and Department of Molecular Medicine, University of Pavia, Pavia, Italy. 17. National Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, Rowland Hill Street, London, NW32PF, UK. 18. Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK. 19. Division of Molecular Patholog, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK. 20. National Centre of Tumor Diseases, Heidelberg, Germany. 21. Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120, Heidelberg, Germany. a.foersti@kitz-heidelberg.de. 22. Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany. a.foersti@kitz-heidelberg.de. 23. Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany. a.foersti@kitz-heidelberg.de.
Authors: Molly Went; Alex J Cornish; Philip J Law; Ben Kinnersley; Mark van Duin; Niels Weinhold; Asta Försti; Markus Hansson; Pieter Sonneveld; Hartmut Goldschmidt; Gareth J Morgan; Kari Hemminki; Björn Nilsson; Martin Kaiser; Richard S Houlston Journal: Blood Adv Date: 2020-05-26
Authors: Alyssa Clay-Gilmour; Subhayan Chattopadhyay; Celine M Vachon; Kari Hemminki; Michelle A T Hildebrandt; Hauke Thomsen; Niels Weinhold; Pavel Vodicka; Ludmila Vodickova; Per Hoffmann; Markus M Nöthen; Karl-Heinz Jöckel; Börge Schmidt; Christian Langer; Roman Hajek; Göran Hallmans; Ulrika Pettersson-Kymmer; Claes Ohlsson; Florentin Späth; Richard Houlston; Hartmut Goldschmidt; Elisabet E Manasanch; Aaron Norman; Shaji Kumar; S Vincent Rajkumar; Susan Slager; Asta Försti Journal: Blood Cancer J Date: 2022-04-13 Impact factor: 11.037
Authors: M Jurado; J Sainz; J M Sánchez-Maldonado; D Campa; J Springer; J Badiola; Y Niazi; A Moñiz-Díez; F Hernández-Mohedo; P González-Sierra; R Ter Horst; A Macauda; S Brezina; C Cunha; M Lackner; M A López-Nevot; L Fianchi; L Pagano; E López-Fernández; L Potenza; M Luppi; L Moratalla; J J Rodríguez-Sevilla; J E Fonseca; M Tormo; C Solano; E Clavero; A Romero; Y Li; C Lass-Flörl; H Einsele; L Vazquez; J Loeffler; K Hemminki; A Carvalho; M G Netea; A Gsur; C Dumontet; F Canzian; A Försti Journal: Blood Cancer J Date: 2020-07-16 Impact factor: 11.037